Overall survival
deaths
The deaths of 52 patients resulted in a 3-year actual OS rate of 86.0% (18 of 129) in the ICG group and 73.6% (34 of 129) in the non-ICG group. The OS in the ICG group was statistically significantly better than that in the non-ICG group (log-rank 